C129H130Cl5F8LiN18O21 — CID 158925694
lithium;3-acetyl-1-[2-[[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-propan-2-ylamino]-2-oxoethyl]indazole-5-carboxylic acid;N-[3-acetyl-1-[2-[[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-propan-2-ylamino]-2-oxoethyl]indazol-5-yl]-3,3-difluoropiperidine-1-carboxamide;2-[3-acetyl-5-(2-hydroxyacetyl)indazol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-propan-2-ylacetamide;2-(3-acetyl-5-methoxycarbonylindazol-1-yl)acetic acid;N-[3-(2-chlorophenyl)-2-fluorophenyl]-4-methylpentanamide;3,3-difluoropiperidine;hydroxide;hydrochloride (PubChem CID 158925694) has the molecular formula C129H130Cl5F8LiN18O21 and a molecular weight of 2604.75 g/mol. Its IUPAC name is lithium;3-acetyl-1-[2-[[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-propan-2-ylamino]-2-oxoethyl]indazole-5-carboxylic acid;N-[3-acetyl-1-[2-[[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-propan-2-ylamino]-2-oxoethyl]indazol-5-yl]-3,3-difluoropiperidine-1-carboxamide;2-[3-acetyl-5-(2-hydroxyacetyl)indazol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-propan-2-ylacetamide;2-(3-acetyl-5-methoxycarbonylindazol-1-yl)acetic acid;N-[3-(2-chlorophenyl)-2-fluorophenyl]-4-methylpentanamide;3,3-difluoropiperidine;hydroxide;hydrochloride.
| Compound Name | lithium;3-acetyl-1-[2-[[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-propan-2-ylamino]-2-oxoethyl]indazole-5-carboxylic acid;N-[3-acetyl-1-[2-[[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-propan-2-ylamino]-2-oxoethyl]indazol-5-yl]-3,3-difluoropiperidine-1-carboxamide;2-[3-acetyl-5-(2-hydroxyacetyl)indazol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-propan-2-ylacetamide;2-(3-acetyl-5-methoxycarbonylindazol-1-yl)acetic acid;N-[3-(2-chlorophenyl)-2-fluorophenyl]-4-methylpentanamide;3,3-difluoropiperidine;hydroxide;hydrochloride |
|---|---|
| PubChem CID | 158925694 |
| Molecular Formula | C129H130Cl5F8LiN18O21 |
| Molecular Weight | 2604.75 g/mol |
| Exact Mass | 2600.81 |
| IUPAC Name | lithium;3-acetyl-1-[2-[[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-propan-2-ylamino]-2-oxoethyl]indazole-5-carboxylic acid;N-[3-acetyl-1-[2-[[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-propan-2-ylamino]-2-oxoethyl]indazol-5-yl]-3,3-difluoropiperidine-1-carboxamide;2-[3-acetyl-5-(2-hydroxyacetyl)indazol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-propan-2-ylacetamide;2-(3-acetyl-5-methoxycarbonylindazol-1-yl)acetic acid;N-[3-(2-chlorophenyl)-2-fluorophenyl]-4-methylpentanamide;3,3-difluoropiperidine;hydroxide;hydrochloride |
| SMILES | CC(=O)c1nn(CC(=O)N(CC(=O)Nc2cccc(-c3ccccc3Cl)c2F)C(C)C)c2ccc(C(=O)CO)cc12.CC(=O)c1nn(CC(=O)N(CC(=O)Nc2cccc(-c3ccccc3Cl)c2F)C(C)C)c2ccc(C(=O)O)cc12.CC(=O)c1nn(CC(=O)N(CC(=O)Nc2cccc(-c3ccccc3Cl)c2F)C(C)C)c2ccc(NC(=O)N3CCCC(F)(F)C3)cc12.CC(C)CCC(=O)Nc1cccc(-c2ccccc2Cl)c1F.COC(=O)c1ccc2c(c1)c(C(C)=O)nn2CC(=O)O.Cl.FC1(F)CCCNC1.[Li+].[OH-] |
| InChI | InChI=1S/C34H34ClF3N6O4.C30H28ClFN4O5.C29H26ClFN4O5.C18H19ClFNO.C13H12N2O5.C5H9F2N.ClH.Li.H2O/c1-20(2)43(17-29(46)40-27-11-6-9-24(31(27)36)23-8-4-5-10-26(23)35)30(47)18-44-28-13-12-22(16-25(28)32(41-44)21(3)45)39-33(48)42-15-7-14-34(37,38)19-42;1-17(2)35(14-27(40)33-24-10-6-8-21(29(24)32)20-7-4-5-9-23(20)31)28(41)15-36-25-12-11-19(26(39)16-37)13-22(25)30(34-36)18(3)38;1-16(2)34(14-25(37)32-23-10-6-8-20(27(23)31)19-7-4-5-9-22(19)30)26(38)15-35-24-12-11-18(29(39)40)13-21(24)28(33-35)17(3)36;1-12(2)10-11-17(22)21-16-9-5-7-14(18(16)20)13-6-3-4-8-15(13)19;1-7(16)12-9-5-8(13(19)20-2)3-4-10(9)15(14-12)6-11(17)18;6-5(7)2-1-3-8-4-5;;;/h4-6,8-13,16,20H,7,14-15,17-19H2,1-3H3,(H,39,48)(H,40,46);4-13,17,37H,14-16H2,1-3H3,(H,33,40);4-13,16H,14-15H2,1-3H3,(H,32,37)(H,39,40);3-9,12H,10-11H2,1-2H3,(H,21,22);3-5H,6H2,1-2H3,(H,17,18);8H,1-4H2;1H;;1H2/q;;;;;;;+1;/p-1 |
| InChIKey | CPDZZIVQLMTGRI-UHFFFAOYSA-M |
| XLogP | 21.74 |
| TPSA | 529.46 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 28 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 182 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2604.75 |
| LogP ≤ 5 | 21.74 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 28 |